Home / Community News / A Patient Videoconference on Inhibitors & New Novel Therapies – Answering Your Questions!

A Patient Videoconference on Inhibitors & New Novel Therapies – Answering Your Questions!

| 04/11/2020

 

On November 2, 2020, the CHS held a live educational videoconference aimed to improve the understanding of FVIII/FIX inhibitors and treatment options, with a special focus on emicizumab. The topics of the webinar included the following:

  • Introduction to inhibitor development – who and why? (Dr. Georges-Étienne Rivard)
  • How patients with inhibitors have been historically managed and what has changed (Dr. Manuel Carcao)
  • Emicizumab – what is it and what do studies tell us about its effectiveness and safety (Dr. Jerry Teitel)
  • Practical aspects of being on emicizumab (Vanessa Bouskill, MN, RN[EC])
  • How to manage bleeds and surgery when on emicizumab (Dr. Jean St-Louis)
  • The future of immune tolerance induction (ITI) therapy and bypassing agent (FEIBA/rFVIIa) (Dr. Manuel Carcao)
Canadian Hemophilia Society
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.